You just read:

Oasmia Has Submitted a Marketing Authorization Application to the European Medicines Agency for Its Lead Cancer Product Apealea® (Paclical®)

News provided by

Oasmia Pharmaceutical AB

08 Feb, 2016, 07:50 GMT